Skip to main content
logo
Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
5.89
+0.08 (1.29%)
Jun 16, 2026, 9:51 AM EDT - Market open

Verrica Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
37.1635.587.575.129.0312
Revenue Growth (YoY)
417.64%370.22%47.66%-43.27%-24.73%-
Cost of Revenue
3.893.442.740.750.73-
Gross Profit
33.2732.144.834.388.3112
Selling, General & Admin
36.3635.2258.8247.3117.4126.98
Research & Development
10.438.8611.8420.312.215.93
Other Operating Expenses
0.250.250.082.54--
Total Operating Expenses
47.0444.3270.7570.1429.642.91
Operating Income
-13.77-12.19-65.92-65.76-21.3-30.91
Interest Income
0.790.931.422.740.480.12
Interest Expense
-5.7-7.74-9.41-3.96-2.17-4.3
Other Non-Operating Income (Expense)
0.851.11-2.67-0.01-1.5-
Total Non-Operating Income (Expense)
-4.06-5.7-10.66-1.24-3.19-4.17
Pretax Income
-17.83-17.89-76.58-67-24.49-35.08
Net Income
-17.83-17.89-76.58-67-24.49-35.08
Net Income to Common
-17.83-17.89-76.58-67-24.49-35.08
Shares Outstanding (Basic)
14115533
Shares Outstanding (Diluted)
14115533
Shares Change (YoY)
112.92%105.61%14.26%32.72%26.32%8.20%
EPS (Basic)
-1.03-1.68-14.78-14.80-7.20-13.00
EPS (Diluted)
-1.03-1.68-14.78-14.80-7.20-13.00
Free Cash Flow
--17.63-60.95-38.94-18.95-28.47
Free Cash Flow Per Share
--1.65-11.77-8.59-5.55-10.53
Gross Margin
89.52%90.33%63.79%85.44%91.97%100.00%
Operating Margin
-37.05%-34.25%-871.25%-1283.35%-235.78%-257.57%
Profit Margin
-47.97%-50.27%-1012.15%-1307.47%-271.11%-292.33%
FCF Margin
--49.55%-805.63%-759.93%-209.83%-237.21%
EBITDA
-13.77-11.4-64.65-64.92-20.58-30.44
EBITDA Margin
-37.05%-32.05%-854.48%-1267.04%-227.83%-253.63%
EBIT
-13.77-12.19-65.92-65.76-21.3-30.91
EBIT Margin
-37.05%-34.25%-871.25%-1283.35%-235.78%-257.57%
SEC Filings: 10-K · 10-Q